This video describes the development of HIV vaccine candidates and the launch of the HVTN 702 clinical trial.
The third annual South African Stock Outs National Survey finds lack of consistent improvement in decreasing medication stock outs in public health care facilities around the country. Results vary by province and specific medications.
Presently, according to WHO, outbreaks of yellow fever are occurring in more than six of Angola’s 18 provinces. Should yellow fever outbreaks occur elsewhere in Africa, in Latin America, or in Asia, current global supplies of yellow fever vaccine will be inadequate.
A vaccine to prevent infection and disease caused by P. vivax is critical to reduce sickness and mortality from vivax malaria, a common cause of malaria among deployed service members. P. vivax malaria is challenging to control because it can be dormant, causing no symptoms, and then become active causing symptomatic malaria weeks to months after initial infection.